A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice
Clinical trial NCT04178317 · COMPLETED
Trial details
- NCT number
- NCT04178317
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-04-02
- Primary completion
- 2025-08-18
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.